Specialty was always going to be hit hard from COVID. When E4 launches it will triple in size. This is a reasonable result all things considered, and for the broad business it shows stabilization for H1 to H2 with a pandemic in the middle. Now, we sit and wait for big FDA approvals x2 this half and E4 next half.
- Forums
- ASX - By Stock
- MYX
- Ann: 2020 Full Year Media Release
MYX
mayne pharma group limited
Add to My Watchlist
1.79%
!
$5.11

Ann: 2020 Full Year Media Release, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.11 |
Change
0.090(1.79%) |
Mkt cap ! $414.3M |
Open | High | Low | Value | Volume |
$5.05 | $5.17 | $5.05 | $489.5K | 95.87K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 255 | $5.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.11 | 300 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 259 | 5.110 |
8 | 353 | 5.100 |
8 | 957 | 5.090 |
5 | 550 | 5.080 |
2 | 680 | 5.070 |
Price($) | Vol. | No. |
---|---|---|
5.120 | 780 | 1 |
5.130 | 1084 | 4 |
5.140 | 379 | 3 |
5.150 | 1776 | 8 |
5.160 | 670 | 4 |
Last trade - 15.12pm 30/07/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |